NEW YORK (360Dx) – Chembio Diagnostics said today that it has received a commitment from Bio-Manguinhos for the purchase of $8.5 million worth of materials related to its HIV and Leishmania point-of-care immunoassays.
NEW YORK (360Dx) – Chembio Diagnostics said today that it has received a commitment from Bio-Manguinhos for the purchase of $8.5 million worth of materials related to its HIV and Leishmania point-of-care immunoassays.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.